drugset / Trial / NCT06770881
JSKN033 in Chinese Subjects with Advanced Malignant Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a phase I/II multicenter study to evaluate the safety and efficacy of JSKN033 in Chinese subjects with unresectable locally advanced/metastatic solid tumors.
Timeline
- Start
- 2025-01-15
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JSKN033 | Unknown | — | Subcutaneous |